Loading…
Cyclin E1 Deregulation Occurs Early in Secretory Cell Transformation to Promote Formation of Fallopian Tube-Derived High-Grade Serous Ovarian Cancers
The fallopian tube is now generally considered the dominant site of origin for high-grade serous ovarian carcinoma. However, the molecular pathogenesis of fallopian tube-derived serous carcinomas is poorly understood and there are few experimental studies examining the transformation of human fallop...
Saved in:
Published in: | Cancer research (Chicago, Ill.) Ill.), 2014-02, Vol.74 (4), p.1141-1152 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c493t-17d9d2006ffe8bb02834dc4e14736dd34f362db195f83359edee0232e898364e3 |
---|---|
cites | cdi_FETCH-LOGICAL-c493t-17d9d2006ffe8bb02834dc4e14736dd34f362db195f83359edee0232e898364e3 |
container_end_page | 1152 |
container_issue | 4 |
container_start_page | 1141 |
container_title | Cancer research (Chicago, Ill.) |
container_volume | 74 |
creator | KARST, Alison M JONES, Paul M VENA, Natalie LIGON, Azra H LIU, Joyce F HIRSCH, Michelle S ETEMADMOGHADAM, Dariush BOWTELL, David D. L DRAPKIN, Ronny |
description | The fallopian tube is now generally considered the dominant site of origin for high-grade serous ovarian carcinoma. However, the molecular pathogenesis of fallopian tube-derived serous carcinomas is poorly understood and there are few experimental studies examining the transformation of human fallopian tube cells. Prompted by recent genomic analyses that identified cyclin E1 (CCNE1) gene amplification as a candidate oncogenic driver in high-grade serous ovarian carcinoma, we evaluated the functional role of cyclin E1 in serous carcinogenesis. Cyclin E1 was expressed in early- and late-stage human tumor samples. In primary human fallopian tube secretory epithelial cells, cyclin E1 expression imparted malignant characteristics to untransformed cells if p53 was compromised, promoting an accumulation of DNA damage and altered transcription of DNA damage response genes related to DNA replication stress. Together, our findings corroborate the hypothesis that cyclin E1 dysregulation acts to drive malignant transformation in fallopian tube secretory cells that are the site of origin of high-grade serous ovarian carcinomas. |
doi_str_mv | 10.1158/0008-5472.CAN-13-2247 |
format | article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4517944</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>24366882</sourcerecordid><originalsourceid>FETCH-LOGICAL-c493t-17d9d2006ffe8bb02834dc4e14736dd34f362db195f83359edee0232e898364e3</originalsourceid><addsrcrecordid>eNpVkV1r2zAUhsXYaLOuP2FDN7t0p09bvhkUN2kHZRksuxaydJR6KFaQ7EB-yP7vbNJl7ZWQzvO-B_Qg9JGSG0ql-kIIUYUUFbtpbr8XlBeMieoNWlDJVVEJId-ixZm5RO9z_j1dJSXyAl0ywctSKbZAf5qjDV2PlxTfQYLtGMzQxR6vrR1TxkuTwhFP859gEwwxHXEDIeBNMn32Me1O9BDxjxR3cQC8Oj9Gj1cmhLjvTI83YwvFtKE7gMMP3fapuE_GwdSb4pjx-mDSjDWmt5DyB_TOm5Dh-vm8Qr9Wy03zUDyu7781t4-FFTUfClq52jFCSu9BtS1higtnBVBR8dI5LjwvmWtpLb3iXNbgAAjjDFSteCmAX6Gvp9792O7AWeiHZILep25n0lFH0-nXk7570tt40ELSqhZiKpCnAptizgn8OUuJnj3p2YGeHejJk6Zcz56m3KeXi8-pf2Im4PMzYLI1wU__bbv8n1O8Kmuh-F8TWZ6q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Cyclin E1 Deregulation Occurs Early in Secretory Cell Transformation to Promote Formation of Fallopian Tube-Derived High-Grade Serous Ovarian Cancers</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>KARST, Alison M ; JONES, Paul M ; VENA, Natalie ; LIGON, Azra H ; LIU, Joyce F ; HIRSCH, Michelle S ; ETEMADMOGHADAM, Dariush ; BOWTELL, David D. L ; DRAPKIN, Ronny</creator><creatorcontrib>KARST, Alison M ; JONES, Paul M ; VENA, Natalie ; LIGON, Azra H ; LIU, Joyce F ; HIRSCH, Michelle S ; ETEMADMOGHADAM, Dariush ; BOWTELL, David D. L ; DRAPKIN, Ronny</creatorcontrib><description>The fallopian tube is now generally considered the dominant site of origin for high-grade serous ovarian carcinoma. However, the molecular pathogenesis of fallopian tube-derived serous carcinomas is poorly understood and there are few experimental studies examining the transformation of human fallopian tube cells. Prompted by recent genomic analyses that identified cyclin E1 (CCNE1) gene amplification as a candidate oncogenic driver in high-grade serous ovarian carcinoma, we evaluated the functional role of cyclin E1 in serous carcinogenesis. Cyclin E1 was expressed in early- and late-stage human tumor samples. In primary human fallopian tube secretory epithelial cells, cyclin E1 expression imparted malignant characteristics to untransformed cells if p53 was compromised, promoting an accumulation of DNA damage and altered transcription of DNA damage response genes related to DNA replication stress. Together, our findings corroborate the hypothesis that cyclin E1 dysregulation acts to drive malignant transformation in fallopian tube secretory cells that are the site of origin of high-grade serous ovarian carcinomas.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>DOI: 10.1158/0008-5472.CAN-13-2247</identifier><identifier>PMID: 24366882</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Antineoplastic agents ; Biological and medical sciences ; Cell Proliferation ; Cell Transformation, Neoplastic - genetics ; Cyclin E - genetics ; Cyclin E - metabolism ; Cystadenocarcinoma, Serous - genetics ; Cystadenocarcinoma, Serous - metabolism ; Cystadenocarcinoma, Serous - secondary ; Epithelial Cells - pathology ; Epithelial Cells - secretion ; Fallopian Tube Neoplasms - genetics ; Fallopian Tube Neoplasms - pathology ; Fallopian Tubes - metabolism ; Fallopian Tubes - pathology ; Female ; Female genital diseases ; Gene Amplification - physiology ; Gene Expression Regulation, Neoplastic ; Gynecology. Andrology. Obstetrics ; Humans ; Medical sciences ; Multiple tumors. Solid tumors. Tumors in childhood (general aspects) ; Oncogene Proteins - genetics ; Oncogene Proteins - metabolism ; Ovarian Neoplasms - genetics ; Ovarian Neoplasms - metabolism ; Ovarian Neoplasms - secondary ; Pharmacology. Drug treatments ; Tissue Array Analysis ; Tumor Cells, Cultured ; Tumors</subject><ispartof>Cancer research (Chicago, Ill.), 2014-02, Vol.74 (4), p.1141-1152</ispartof><rights>2015 INIST-CNRS</rights><rights>2013 AACR.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c493t-17d9d2006ffe8bb02834dc4e14736dd34f362db195f83359edee0232e898364e3</citedby><cites>FETCH-LOGICAL-c493t-17d9d2006ffe8bb02834dc4e14736dd34f362db195f83359edee0232e898364e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28376948$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24366882$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KARST, Alison M</creatorcontrib><creatorcontrib>JONES, Paul M</creatorcontrib><creatorcontrib>VENA, Natalie</creatorcontrib><creatorcontrib>LIGON, Azra H</creatorcontrib><creatorcontrib>LIU, Joyce F</creatorcontrib><creatorcontrib>HIRSCH, Michelle S</creatorcontrib><creatorcontrib>ETEMADMOGHADAM, Dariush</creatorcontrib><creatorcontrib>BOWTELL, David D. L</creatorcontrib><creatorcontrib>DRAPKIN, Ronny</creatorcontrib><title>Cyclin E1 Deregulation Occurs Early in Secretory Cell Transformation to Promote Formation of Fallopian Tube-Derived High-Grade Serous Ovarian Cancers</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>The fallopian tube is now generally considered the dominant site of origin for high-grade serous ovarian carcinoma. However, the molecular pathogenesis of fallopian tube-derived serous carcinomas is poorly understood and there are few experimental studies examining the transformation of human fallopian tube cells. Prompted by recent genomic analyses that identified cyclin E1 (CCNE1) gene amplification as a candidate oncogenic driver in high-grade serous ovarian carcinoma, we evaluated the functional role of cyclin E1 in serous carcinogenesis. Cyclin E1 was expressed in early- and late-stage human tumor samples. In primary human fallopian tube secretory epithelial cells, cyclin E1 expression imparted malignant characteristics to untransformed cells if p53 was compromised, promoting an accumulation of DNA damage and altered transcription of DNA damage response genes related to DNA replication stress. Together, our findings corroborate the hypothesis that cyclin E1 dysregulation acts to drive malignant transformation in fallopian tube secretory cells that are the site of origin of high-grade serous ovarian carcinomas.</description><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Cell Proliferation</subject><subject>Cell Transformation, Neoplastic - genetics</subject><subject>Cyclin E - genetics</subject><subject>Cyclin E - metabolism</subject><subject>Cystadenocarcinoma, Serous - genetics</subject><subject>Cystadenocarcinoma, Serous - metabolism</subject><subject>Cystadenocarcinoma, Serous - secondary</subject><subject>Epithelial Cells - pathology</subject><subject>Epithelial Cells - secretion</subject><subject>Fallopian Tube Neoplasms - genetics</subject><subject>Fallopian Tube Neoplasms - pathology</subject><subject>Fallopian Tubes - metabolism</subject><subject>Fallopian Tubes - pathology</subject><subject>Female</subject><subject>Female genital diseases</subject><subject>Gene Amplification - physiology</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Multiple tumors. Solid tumors. Tumors in childhood (general aspects)</subject><subject>Oncogene Proteins - genetics</subject><subject>Oncogene Proteins - metabolism</subject><subject>Ovarian Neoplasms - genetics</subject><subject>Ovarian Neoplasms - metabolism</subject><subject>Ovarian Neoplasms - secondary</subject><subject>Pharmacology. Drug treatments</subject><subject>Tissue Array Analysis</subject><subject>Tumor Cells, Cultured</subject><subject>Tumors</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNpVkV1r2zAUhsXYaLOuP2FDN7t0p09bvhkUN2kHZRksuxaydJR6KFaQ7EB-yP7vbNJl7ZWQzvO-B_Qg9JGSG0ql-kIIUYUUFbtpbr8XlBeMieoNWlDJVVEJId-ixZm5RO9z_j1dJSXyAl0ywctSKbZAf5qjDV2PlxTfQYLtGMzQxR6vrR1TxkuTwhFP859gEwwxHXEDIeBNMn32Me1O9BDxjxR3cQC8Oj9Gj1cmhLjvTI83YwvFtKE7gMMP3fapuE_GwdSb4pjx-mDSjDWmt5DyB_TOm5Dh-vm8Qr9Wy03zUDyu7781t4-FFTUfClq52jFCSu9BtS1higtnBVBR8dI5LjwvmWtpLb3iXNbgAAjjDFSteCmAX6Gvp9792O7AWeiHZILep25n0lFH0-nXk7570tt40ELSqhZiKpCnAptizgn8OUuJnj3p2YGeHejJk6Zcz56m3KeXi8-pf2Im4PMzYLI1wU__bbv8n1O8Kmuh-F8TWZ6q</recordid><startdate>20140215</startdate><enddate>20140215</enddate><creator>KARST, Alison M</creator><creator>JONES, Paul M</creator><creator>VENA, Natalie</creator><creator>LIGON, Azra H</creator><creator>LIU, Joyce F</creator><creator>HIRSCH, Michelle S</creator><creator>ETEMADMOGHADAM, Dariush</creator><creator>BOWTELL, David D. L</creator><creator>DRAPKIN, Ronny</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20140215</creationdate><title>Cyclin E1 Deregulation Occurs Early in Secretory Cell Transformation to Promote Formation of Fallopian Tube-Derived High-Grade Serous Ovarian Cancers</title><author>KARST, Alison M ; JONES, Paul M ; VENA, Natalie ; LIGON, Azra H ; LIU, Joyce F ; HIRSCH, Michelle S ; ETEMADMOGHADAM, Dariush ; BOWTELL, David D. L ; DRAPKIN, Ronny</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c493t-17d9d2006ffe8bb02834dc4e14736dd34f362db195f83359edee0232e898364e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Cell Proliferation</topic><topic>Cell Transformation, Neoplastic - genetics</topic><topic>Cyclin E - genetics</topic><topic>Cyclin E - metabolism</topic><topic>Cystadenocarcinoma, Serous - genetics</topic><topic>Cystadenocarcinoma, Serous - metabolism</topic><topic>Cystadenocarcinoma, Serous - secondary</topic><topic>Epithelial Cells - pathology</topic><topic>Epithelial Cells - secretion</topic><topic>Fallopian Tube Neoplasms - genetics</topic><topic>Fallopian Tube Neoplasms - pathology</topic><topic>Fallopian Tubes - metabolism</topic><topic>Fallopian Tubes - pathology</topic><topic>Female</topic><topic>Female genital diseases</topic><topic>Gene Amplification - physiology</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Multiple tumors. Solid tumors. Tumors in childhood (general aspects)</topic><topic>Oncogene Proteins - genetics</topic><topic>Oncogene Proteins - metabolism</topic><topic>Ovarian Neoplasms - genetics</topic><topic>Ovarian Neoplasms - metabolism</topic><topic>Ovarian Neoplasms - secondary</topic><topic>Pharmacology. Drug treatments</topic><topic>Tissue Array Analysis</topic><topic>Tumor Cells, Cultured</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KARST, Alison M</creatorcontrib><creatorcontrib>JONES, Paul M</creatorcontrib><creatorcontrib>VENA, Natalie</creatorcontrib><creatorcontrib>LIGON, Azra H</creatorcontrib><creatorcontrib>LIU, Joyce F</creatorcontrib><creatorcontrib>HIRSCH, Michelle S</creatorcontrib><creatorcontrib>ETEMADMOGHADAM, Dariush</creatorcontrib><creatorcontrib>BOWTELL, David D. L</creatorcontrib><creatorcontrib>DRAPKIN, Ronny</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KARST, Alison M</au><au>JONES, Paul M</au><au>VENA, Natalie</au><au>LIGON, Azra H</au><au>LIU, Joyce F</au><au>HIRSCH, Michelle S</au><au>ETEMADMOGHADAM, Dariush</au><au>BOWTELL, David D. L</au><au>DRAPKIN, Ronny</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cyclin E1 Deregulation Occurs Early in Secretory Cell Transformation to Promote Formation of Fallopian Tube-Derived High-Grade Serous Ovarian Cancers</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>2014-02-15</date><risdate>2014</risdate><volume>74</volume><issue>4</issue><spage>1141</spage><epage>1152</epage><pages>1141-1152</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>The fallopian tube is now generally considered the dominant site of origin for high-grade serous ovarian carcinoma. However, the molecular pathogenesis of fallopian tube-derived serous carcinomas is poorly understood and there are few experimental studies examining the transformation of human fallopian tube cells. Prompted by recent genomic analyses that identified cyclin E1 (CCNE1) gene amplification as a candidate oncogenic driver in high-grade serous ovarian carcinoma, we evaluated the functional role of cyclin E1 in serous carcinogenesis. Cyclin E1 was expressed in early- and late-stage human tumor samples. In primary human fallopian tube secretory epithelial cells, cyclin E1 expression imparted malignant characteristics to untransformed cells if p53 was compromised, promoting an accumulation of DNA damage and altered transcription of DNA damage response genes related to DNA replication stress. Together, our findings corroborate the hypothesis that cyclin E1 dysregulation acts to drive malignant transformation in fallopian tube secretory cells that are the site of origin of high-grade serous ovarian carcinomas.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>24366882</pmid><doi>10.1158/0008-5472.CAN-13-2247</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-5472 |
ispartof | Cancer research (Chicago, Ill.), 2014-02, Vol.74 (4), p.1141-1152 |
issn | 0008-5472 1538-7445 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4517944 |
source | EZB-FREE-00999 freely available EZB journals |
subjects | Antineoplastic agents Biological and medical sciences Cell Proliferation Cell Transformation, Neoplastic - genetics Cyclin E - genetics Cyclin E - metabolism Cystadenocarcinoma, Serous - genetics Cystadenocarcinoma, Serous - metabolism Cystadenocarcinoma, Serous - secondary Epithelial Cells - pathology Epithelial Cells - secretion Fallopian Tube Neoplasms - genetics Fallopian Tube Neoplasms - pathology Fallopian Tubes - metabolism Fallopian Tubes - pathology Female Female genital diseases Gene Amplification - physiology Gene Expression Regulation, Neoplastic Gynecology. Andrology. Obstetrics Humans Medical sciences Multiple tumors. Solid tumors. Tumors in childhood (general aspects) Oncogene Proteins - genetics Oncogene Proteins - metabolism Ovarian Neoplasms - genetics Ovarian Neoplasms - metabolism Ovarian Neoplasms - secondary Pharmacology. Drug treatments Tissue Array Analysis Tumor Cells, Cultured Tumors |
title | Cyclin E1 Deregulation Occurs Early in Secretory Cell Transformation to Promote Formation of Fallopian Tube-Derived High-Grade Serous Ovarian Cancers |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T08%3A39%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cyclin%20E1%20Deregulation%20Occurs%20Early%20in%20Secretory%20Cell%20Transformation%20to%20Promote%20Formation%20of%20Fallopian%20Tube-Derived%20High-Grade%20Serous%20Ovarian%20Cancers&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=KARST,%20Alison%20M&rft.date=2014-02-15&rft.volume=74&rft.issue=4&rft.spage=1141&rft.epage=1152&rft.pages=1141-1152&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/10.1158/0008-5472.CAN-13-2247&rft_dat=%3Cpubmed_cross%3E24366882%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c493t-17d9d2006ffe8bb02834dc4e14736dd34f362db195f83359edee0232e898364e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/24366882&rfr_iscdi=true |